What is Depo-Provera?
Depo-Provera is made up of a synthetic progesterone, and is administered via injection by a doctor into a woman’s arm or buttocks. Each shot protects against pregnancy for up to 14 weeks, but the shot must be received once every 12 weeks for the woman to remain fully protected. Depo-Provera is manufactured by Pfizer, and was approved by the U.S. Food & Drug Administration (FDA) in October 1992.
Depo-Provera and PTC
In December of 2012, a report funded by the U.K.’s Faculty of Sexual and Reproductive Healthcare described a case report of a 23-year-old Depo-Provera user who developed pseudotumor cerebri. The woman’s only medication was Depo-Provera, which she had only been administered one dose of two months prior to being diagnosed with PTC. She discontinued treatment with the drug and recovered fully within four months.
Pseudotumor Cerebri Symptoms
The most common symptom of PTC is severe headache. The headache has been described as throbbing in nature. Other symptoms of associated with pseudotumor cerebri may include:
- Blurred vision
- Double vision (diplopia)
- Eye injury (papilledema)
- Buzzing sound in the ears (tinnitus)
- Vision loss
Depo-Provera Linked to Increased Risk of HIV: Meta-Analysis
Increased rates of human immunodeficiency virus (HIV) were seen among women who used Depo-Provera compared to women who used other forms of birth control, according to a new meta-analysis. Potential links between Depo-Provera and incidences of HIV infection have been noted in the medical literature for more than 20 years, the authors explained in The Lancet Infectious Diseases. Click here to learn more.